Recurrence of Diabetic Nephropathy in Renal Transplants

  • Sven-Olof Bohman
  • Henryk Wilczek
  • Georg Jaremko
  • Gunnar Tydén
Part of the Topics in Renal Medicine book series (TIRM, volume 6)


The first systematic studies of recurrent diabetic nephropathy in human renal transplants were carried out by the Minneapolis group [1, 2]. A light-microscopic study [1] showed that hyaline arteriolosclerosis had developed in all renal transplants of diabetic patients studied within 5 years after the transplantation. In several cases, it was shown that both the afferent and the efferent arterioles were affected, a condition considered more or less pathognomonic for diabetic nephropathy [3]. One of the biopsies also showed typical nodular glomerulosclerosis that had developed within 4 1/2 years after the transplantation [1].


Diabetic Nephropathy Glomerular Basement Membrane Renal Allograft Pancreas Transplantation Basement Membrane Thickness 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mauer SM, Barbosa J, Vernier RL, Kjellstrand CM, Buselmeier TJ, Simmons RL, Najarian JS: Development of diabetic vascular lesions in normal kidneys transplanted into patients with diabetes mellitus. N Engl J Med 295: 916–920, 1976.PubMedCrossRefGoogle Scholar
  2. 2.
    Mauer SM, Miller K, Goetz FC, Barbosa J, Simmons RL, Najarian JS, Michael AF: Immunopathology of renal extracellular membranes in kidneys transplanted into patients with diabetes mellitus. Diabetes 25: 709–712, 1976.PubMedCrossRefGoogle Scholar
  3. 3.
    Heptinstall RH: Pathology of the kidney, vols 1 and 3, 3rd edn. Boston: Little, Brown and Company, 1983.Google Scholar
  4. 4.
    Westberg NG, Michael AF: Immunohistopathology of diabetic glomerulosclerosis. Diabetes 21: 163–174, 1972.PubMedGoogle Scholar
  5. 5.
    Melvin T, Kim Y, Michael AF: Selective binding of IgG.r and other negatively charged plasma proteins in normal and diabetic human kidneys. Am J Pathol 115: 443–446, 1984.PubMedGoogle Scholar
  6. 6.
    Lee CS, Mauer SM, Brown DM, Sutherland DER, Michael AF, Najarian JS: Renal transplantation in diabetes mellitus in rats. J Exp Med 139: 793–799, 1974.PubMedCrossRefGoogle Scholar
  7. 7.
    Bohman S-O, Wilczek H, Jaremko G, Lundgren G: Recurrence of diabetic nephropathy in human renal allografts: preliminary report of a biopsy study. Transplant Proc 16: 649–653, 1984.PubMedGoogle Scholar
  8. 8.
    Lundgren G, Wilczek H, Bohman S-O, Jaremko G, Groth CG: Development of diabetic nephropathy in renal allografts of diabetic patients. Transplant Proc 17: 18–20, 1985.Google Scholar
  9. 9.
    Bohman S-O, Jaremko G, Lundgren G, Tydén G, Wilczek H, Groth CG: Diabetic nephropathy in kidney transplants of diabetic patients, with a note on the protective effect of concomitant pancreatic transplantation. Diabetic Nephropathy 5: 55–57, 1985.Google Scholar
  10. 10.
    Frejkaer Thomsen O, Andersen AR, Sandahl Christiansen J, Deckert T: Renal changes in long-term type 1 (insulin-dependent) diabetic patients with and without clinical nephropathy: a light microscopic, morphometric study of autopsy material. Diabetologia 26: 361–365, 1984.Google Scholar
  11. 11.
    Deckert T, Parving H-H, Frokjaer Thomsen O, Jorgensen HE, Brun C, Thomsen AC: Renal structure and function in type 1 (insulin-dependent) diabetic patients: a study of 44 kidney biopsies. Diabetic Nephropathy 4: 163–168, 1985.Google Scholar
  12. 12.
    Andersen AR, Christiansen JS, Kreiner S, Deckert T: Diabetic nephropathy in type I (insulin-dependent) diabetes: an epidemiological study. Diabetologia 25: 496–501, 1983.PubMedCrossRefGoogle Scholar
  13. 13.
    Mauer SM, Steffes MW, Ellis EE, Brown DM: Can the insulin-dependent diabetic patient be managed without kidney biopsy? In: Robinson RR (ed) Proceedings of the 9th international congress on nephrology, vol 2. New York: Springer-Verlag, 1984, pp 1103–1108.Google Scholar
  14. 14.
    Barbosa J, Saner B: Do genetic factors play a role in the pathogenesis of diabetic nephropathy? Diabetologia 27: 487–492, 1984.PubMedCrossRefGoogle Scholar
  15. 15.
    Richmond JD, Sturgill BC, Bolton WK: Recurrence of typical diffuse and nodular diabetic glomerulosclerosis in a renal allograft of a diabetic patient: functional deterioration in a six year old graft. Diabetic Nephropathy 3: 28–29, 1984.Google Scholar
  16. 16.
    Maryniak PK, Mendoza N, Clyne D, Balakrishnan K, Weiss MA: Recurrence of diabetic nodular glomerulosclerosis in a renal transplant. Transplantation 39: 35–38, 1985.PubMedCrossRefGoogle Scholar
  17. 17.
    Wilczek H, Gunnarsson R, Lundgren G, Öst L: Improved results of renal transplantation in diabetic nephropathy. Transplant Proc 16: 623–627, 1984.PubMedGoogle Scholar
  18. 18.
    Sutherland DER, Fryd DS, Strand M, Ascher N, Simmons RL, Najarian JS: Results of renal transplantation in diabetics at the University of Minnesota since 1979, including a comparison of outcome in diabetic and nondiabetic recipients randomized to cyclosporine versus azathioprine for immunosuppression. Transplant Proc 16: 629–632, 1984.PubMedGoogle Scholar
  19. 19.
    Mogensen CE: Clinical and renal functional studies of diabetic nephropathy in humans. In: Robinson RR (ed) Proceedings of the 9th international congress on nephrology, vol 2. New York: Springer-Verlag, 1984, pp 1053–1073.Google Scholar
  20. 20.
    Hostetter TH, Rennke HG, Brenner BM: The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies. Am J Med 72: 375–380, 1982.PubMedCrossRefGoogle Scholar
  21. 21.
    Zatz R, Brenner BM: Pathogenesis of diabetic microangiopathy: the hemodynamic view. Am J Med 80: 443–453, 1985.CrossRefGoogle Scholar
  22. 22.
    Steffes MW, Brown DM, Mauer MM: Diabetic glomerulopathy following unilateral nephrectomy in the rat. Diabetes 27: 35–41, 1978.PubMedCrossRefGoogle Scholar
  23. 23.
    Osterby R: Morphometric studies of the peripheral glomerular basement membrane in early juvenile diabetes. I. Development of initial basement membrane thickening. Diabetologia 8: 84–89, 1972.PubMedCrossRefGoogle Scholar
  24. 24.
    fsterby R: A quantitative electron microscopic study of mesangial regions in glomeruli from patients with short term juvenile diabetes mellitus. Lab Invest 29: 99–110, 1973.Google Scholar
  25. 25.
    Mauer SM, Steffes MW, Ellis EE, Sutherland DER, Brown DM, Goetz FC: Structural—functional relationships in diabetic nephropathy. J Clin Invest 74: 1143–1155, 1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Mauer SM, Steffes MW, Connett J, Najarian JS, Sutherland DER, Barbosa J: The development of lesions in the glomerular basement membrane and mesangium after transplantation of normal kidneys to diabetic patients. Diabetes 32: 948–952, 1983.PubMedCrossRefGoogle Scholar
  27. 27.
    Osterby R, Anderson AR, Gundersen HJ, Jorgensen HE, Mogensen CE, Parving H-H: Quantitative studies of glomerular ultrastructure in type I diabetics with incipient nephropathy. Diabetic Nephropathy 3: 95–100, 1984.Google Scholar
  28. 28.
    Steffes MW, Barbosa J, Basgen JM, Sutherland DER, Najarian JS, Mauer SM: Quantitative glomerular morphology of the normal human kidney. Lab Invest 49: 82–86, 1983.PubMedGoogle Scholar
  29. 29.
    Steffes MW, Vernier RL, Brown DM, Basgen JM, Mauer SM: Diabetic glomerulopathy in the uninephrectomized rat resists amelioration following islet transplantation. Diabetologia 23: 347–353, 1982.PubMedCrossRefGoogle Scholar
  30. 30.
    Sutherland DER, Moudry KC: Pancreas Transplant Registry report: 1986. Clin Transplant 1: 3–17, 1987.Google Scholar
  31. 31.
    Tydén G, Brattström C, Gunnarsson R, Lundgren G, Ost L, Östman J, Groth CG: Metabolic control 2 months to 4.5 years after pancreatic transplantation with special reference to the role of cyclosporin. Transplant Proc 19: 2294–2296, 1987.PubMedGoogle Scholar
  32. 32.
    Orloff MJ, Yamanaka N, Greenleaf GE, Huang Y-T, Huang D-G, Leng X-S: Reversal of mesangial enlargement in rats with long-standing diabetes by whole pancreas transplantation. Diabetes 35: 347–354, 1986.PubMedCrossRefGoogle Scholar
  33. 33.
    Steffes MW, Brown DM, Basgen JM, Matas AJ, Mauer SM: Glomerular basement membrane thickness following islet transplantation in the rat. Lab Invest 41: 116–118, 1979.PubMedGoogle Scholar
  34. 34.
    Gotzsche O, Gundersen HJG, sterby R: Irreversibility of glomerular basement membrane accumulation despite reversibility of renal hypertrophy with islet transplantation in early experimental diabetes. Diabetes 30: 481–485, 1981.PubMedCrossRefGoogle Scholar
  35. 35.
    Bohman S-O, Tydén G, Wilczek H, Lundgren G, Jaremko G, Gunnarsson R, Östman J, Groth CG: Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 34: 306–308, 1985.PubMedCrossRefGoogle Scholar
  36. 36.
    Bohman S-O, Wilczek H, Tydén G, Jaremko G, Lundgren G, Groth CG: Recurrent diabetic nephropathy in renal allografts placed in diabetic patients and protective effect of simultaneous pancreatic transplantation. Transplant Proc 19: 2290–2293, 1987.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Sven-Olof Bohman
  • Henryk Wilczek
  • Georg Jaremko
  • Gunnar Tydén

There are no affiliations available

Personalised recommendations